跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 10,010 条关于
“SIGNAL-AA”
全部
10,010
临床试验
7,558
药物
374
机构
304
资讯
1,774
去年
Q32 Bio Restructures to Advance Bempikibart Development for Alopecia Areata Treatment
去年
Q32 Bio Names Adrien Sipos as Interim CMO to Lead Alopecia Areata Drug Development
6个月前
Q32 Bio Reports Positive Clinical Progress for Bempikibart in Alopecia Areata with 36-Week Data Expected Mid-2026
去年
Q32 Bio's Bempikibart Shows Mixed Results, BioAge's Azelaprag Faces Safety Concerns, Stocks React
去年
Q32 Bio's Bempikibart Fails Primary Endpoint in Atopic Dermatitis Trial, Alopecia Data Marred by Protocol Issues
去年
Q32 Bio Announces Q3 2024 Results and Highlights Clinical Progress of Bempikibart and ADX-097
去年
Allergan Aesthetics Launches AA Signature Program to Transform Personalized Aesthetic Treatments
去年
FDA Approvals and Clinical Trials Signal Growth for Eli Lilly
去年
REPRIEVE Trial Suggests Abacavir Use Linked to Increased Cardiovascular Risk in People with HIV
去年
Regeneron's Ordspono Shows Promise in Relapsed/Refractory Marginal Zone Lymphoma
第 1 页,共 178 页
上一页
下一页